Dashboard
Manage Tickers

SNSESensei Biotherapeutics, Inc.

Nasdaq senseibio.com


$ 1.60 $ 0.06 (3.97 %)    

Monday, 13-May-2024 14:59:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 1.57
$ 1.58
$ 0.00 x 0
$ 0.00 x 0
$ 1.58 - $ 1.75
$ 0.51 - $ 1.94
229,226
na
39.33M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stephens--co-initiates-coverage-on-sensei-biotherapeutics-with-overweight-rating-announces-price-target-of-5
Stephens & Co. Initiates Coverage On Sense...
05/14/2024 09:48:39

Stephens & Co. analyst Sudan Loganathan initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Overweight rat...

sensei-biotherapeutics-cash-cash-equivalents-and-marketable-securities-were-581m-as-of-march-31-2024-expected-to-fund-operations-into-the-fourth-quarter-of-2025
Sensei Biotherapeutics' Cash, Cash Equival...
05/09/2024 12:36:51

sensei-biotherapeutics-q1-2024-gaap-eps-032-misses-029-estimate
Sensei Biotherapeutics Q1 2024 GAAP EPS $(...
05/09/2024 12:33:48

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 16:31:17

sensei-biotherapeutics-to-present-topline-clinical-data-from-the-sns-101-phase-i-dose-escalation-study-at-the-2024-asco-annual-meeting
Sensei Biotherapeutics To Present Topline ...
04/24/2024 20:52:35

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

sensei-biotherapeutics-announces-nature-communications-publication-describing-mechanism-of-action-of-sns-101-selectively-targeting-the-active-form-of-vista-within-the-tumor-microenvironment
Sensei Biotherapeutics Announces Nature Co...
04/04/2024 20:10:49

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

sensei-biotherapeutics-cfo-to-resign-all-positions-with-co-effective-april-10
Sensei Biotherapeutics CFO To Resign All P...
04/02/2024 11:48:59

-SEC Filing

sensei-biotherapeutics-fy-eps-122-up-from-158-yoy-2023-year-end-cash-cash-equivalents-and-marketable-securities-of-658m-is-expected-to-provide-cash-runway-into-fourth-quarter-of-2025
Sensei Biotherapeutics FY EPS $(1.22) Up F...
02/28/2024 12:36:08

Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(1.22) per share. This is a 22.78 percent increase over loss...

sensei-biotherapeutics-says-it-completed-sns-101-monotherapy-dose-escalation-through-15-mgkg-with-no-dose-limiting-toxicities-highlights-strong-balance-sheet-with-cash-runway-extended-into-q4-of-2025
Sensei Biotherapeutics Says It Completed S...
01/04/2024 12:43:25

hc-wainwright--co-initiates-coverage-on-sensei-biotherapeutics-with-buy-rating-announces-price-target-of-4
HC Wainwright & Co. Initiates Coverage On ...
12/04/2023 11:41:46

HC Wainwright & Co. analyst Edward White initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating an...

sensei-biotherapeutics-q3-eps-028-beats-034-estimate-cash-cash-equivalents-and-marketable-securities-of-72m-expected-to-fund-operations-into-the-second-half-of-2025
Sensei Biotherapeutics Q3 EPS $(0.28) Beat...
11/07/2023 12:42:03

Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate o...

why-best-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why BEST Shares Are Trading Higher By Arou...
11/06/2023 13:08:25

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 1...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/06/2023 13:06:45

on-november-6-2023-sensei-biotherapeutics-confirmed-that-on-october-25-2023-it-received-an-unsolicited-proposal-from-newtyn-management-to-acquire-the-company-at-100-per-share-in-cash
On November 6, 2023, Sensei Biotherapeutic...
11/06/2023 11:16:15

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
11/03/2023 21:31:26

sensei-biotherapeutics-reports-clinical-data-for-sns-101-at-2023-sitc-annual-meeting
Sensei Biotherapeutics Reports Clinical Da...
11/03/2023 20:06:24

- Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacok...

sensei-biotherapeutics-to-present-initial-clinical-data-from-dose-escalation-trial-of-sns-101-at-2023-sitc-annual-meeting
Sensei Biotherapeutics To Present Initial ...
10/25/2023 13:11:19

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

sensei-biotherapeutics-presents-trial-in-progress-poster-for-phase-12-clinical-study-of-sns-101-at-esmo-2023
Sensei Biotherapeutics Presents Trial-in-P...
10/23/2023 11:36:09

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
10/05/2023 17:22:02

  On Thursday, 369 companies hit new 52-week lows.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION